Clinical trial
A Mass Balance Study of [14C]IBI351 in Healthy Male Chinese Subjects
NCT05626179 is registered in ClinicalTrials.gov with Innovent Biologics (Suzhou) Co. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Mass Balance Study of [14C]IBI351 in Healthy Male Chinese Subjects
- Lead sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 18, 2023
- Completion date
- May 18, 2023
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy subjects